{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Akt", "BCAA catabolism", "GSK3\u03b2", "PP2Cm", "insulin resistance", "rosuvastatin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37139700", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "04"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1113/EP090305"], "Journal": {"ISSN": "1469-445X", "JournalIssue": {"Volume": "108", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Jul"}}, "Title": "Experimental physiology", "ISOAbbreviation": "Exp Physiol"}, "ArticleTitle": "High doses of rosuvastatin induce impaired branched-chain amino acid catabolism and lead to insulin resistance.", "Pagination": {"StartPage": "961", "EndPage": "974", "MedlinePgn": "961-974"}, "Abstract": {"AbstractText": ["What is the central question of this study? Is there a risk of developing diabetes associated with statin treatment? What is the underlying mechanism of the increased incidence rate of new-onset diabetes in patients treated with rosuvastatin? What is the main finding and its importance? Rosuvastatin therapy reduced intraperitoneal glucose tolerance and changed the catabolism of branched-chain amino acid (BCAAs) in white adipose tissue and skeletal muscle. Protein phosphatase 2Cm knockdown completely abolished the effects of insulin and rosuvastatin on glucose absorption. This study provides mechanistic support for recent clinical data on rosuvastatin-related new-onset diabetes and underscores the logic for intervening in BCAA catabolism to prevent the harmful effects of rosuvastatin.", "Accumulating evidence indicates that patients treated with rosuvastatin have an increased risk of developing new-onset diabetes. However, the underlying mechanism remains unclear. In this study, we administered rosuvastatin (10\u00a0mg/kg body weight) to male C57BL/6J mice for 12\u00a0weeks and found that oral rosuvastatin dramatically reduced intraperitoneal glucose tolerance. Rosuvastatin-treated mice showed considerably higher serum levels of branched-chain amino acids (BCAAs) than control mice. They also showed dramatically altered expression of BCAA catabolism-related enzymes in white adipose tissue and skeletal muscle, including downregulated mRNA expression of BCAT2 and protein phosphatase 2Cm (PP2Cm) and upregulated mRNA expression of branched-chain ketoacid dehydrogenase kinase (BCKDK). The levels of BCKD in the skeletal muscle were reduced in rosuvastatin-treated mice, which was associated with lower PP2Cm protein levels and increased BCKDK levels. We also investigated the effects of rosuvastatin and insulin administration on glucose metabolism and BCAA catabolism in C2C12 myoblasts. We observed that incubation with insulin enhanced glucose uptake and facilitated BCAA catabolism in C2C12 cells, which was accompanied by elevated Akt and glycogen synthase kinase 3 \u03b2 (GSK3\u03b2) phosphorylation. These effects of insulin were prevented by co-incubation of the cells with 25\u00a0\u03bcM rosuvastatin. Moreover, the effects of insulin and rosuvastatin administration on glucose uptake and Akt and GSK3\u03b2 signaling in C2C12 cells were abolished when PP2Cm was knocked down. Although the relevance of these data, obtained with high doses of rosuvastatin in mice, to therapeutic doses in humans remains to be elucidated, this study highlights a potential mechanism for the diabetogenic effects of rosuvastatin, and suggests that BCAA catabolism could be a pharmacological target for preventing the adverse effects of rosuvastatin."], "CopyrightInformation": "\u00a9 2023 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society."}, "AuthorList": [{"Identifier": ["0000-0002-2342-0812"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China."}], "LastName": "Bai", "ForeName": "Xue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China."}], "LastName": "Long", "ForeName": "Xingzhen", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China."}], "LastName": "Song", "ForeName": "Fang", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China."}], "LastName": "Chen", "ForeName": "Baolin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China."}], "LastName": "Sheng", "ForeName": "Changcheng", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China."}], "LastName": "Tang", "ForeName": "Cailin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China."}], "LastName": "Li", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China."}], "LastName": "Zhang", "ForeName": "Jiaxing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China."}], "LastName": "Zhang", "ForeName": "Rui", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants & College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, Guizhou, China."}], "LastName": "Zhang", "ForeName": "Jiquan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong, China."}], "LastName": "Li", "ForeName": "Jiali", "Initials": "J"}], "GrantList": [{"GrantID": "QKHZC [2018]2801", "Agency": "Science and Technology Support Program of Guizhou Province", "Country": ""}, {"GrantID": "QKHZC (2019)2805", "Agency": "Science and Technology Support Program of Guizhou Province", "Country": ""}, {"GrantID": "GZSYQN [2017]14", "Agency": "Youth Fund of Guizhou Provincial People's Hospital", "Country": ""}, {"GrantID": "gzwjkj2018-1-002", "Agency": "Science and Technology Fund Project of Health and Planning Commission of Guizhou Province", "Country": ""}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Exp Physiol", "NlmUniqueID": "9002940", "ISSNLinking": "0958-0670"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amino Acids, Branched-Chain"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Glycogen Synthase Kinase 3 beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "EC 3.1.3.16", "NameOfSubstance": "Phosphoprotein Phosphatases"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "83MVU38M7Q", "NameOfSubstance": "Rosuvastatin Calcium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Amino Acids, Branched-Chain"}, {"QualifierName": [], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Glucose"}, {"QualifierName": [], "DescriptorName": "Glycogen Synthase Kinase 3 beta"}, {"QualifierName": [], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Phosphoprotein Phosphatases"}, {"QualifierName": [], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Rosuvastatin Calcium"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ambrus, A. , & Adam\u2010Vizi, V. (2018). Human dihydrolipoamide dehydrogenase (E3) deficiency: Novel insights into the structural basis and molecular pathomechanism. Neurochemistry International, 117, 5\u201314.", "ArticleIdList": ["28579060"]}, {"Citation": "Baker, W. L. , Talati, R. , White, C. M. , & Coleman, C. I. (2010). Differing effect of statins on insulin sensitivity in non\u2010diabetics: A systematic review and meta\u2010analysis. Diabetes Research and Clinical Practice, 87(1), 98\u2013107.", "ArticleIdList": ["19913318"]}, {"Citation": "Bjorkhem\u2010Bergman, L. , Lindh, J. D. , & Bergman, P. (2011). What is a relevant statin concentration in cell experiments claiming pleiotropic effects? British Journal of Clinical Pharmacology, 72(1), 164\u2013165.", "ArticleIdList": ["PMC3141200", "21223360"]}, {"Citation": "Bonifacio, A. , Sanvee, G. M. , Bouitbir, J. , & Krahenbuhl, S. (2015). The AKT/mTOR signaling pathway plays a key role in statin\u2010induced myotoxicity. Biochimica et Biophysica Acta, 1853(8), 1841\u20131849.", "ArticleIdList": ["25913013"]}, {"Citation": "Cederberg, H. , Stan\u010d\u00e1kov\u00e1, A. , Yaluri, N. , Modi, S. , Kuusisto, J. , & Laakso, M. (2015). Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: A 6 year follow\u2010up study of the METSIM cohort. Diabetologia, 58(5), 1109\u20131117.", "ArticleIdList": ["25754552"]}, {"Citation": "Corsetti, G. , D'Antona, G. , Ruocco, C. , Stacchiotti, A. , Romano, C. , Tedesco, L. , Dioguardi, F. , Rezzani, R. , & Nisoli, E. (2014). Dietary supplementation with essential amino acids boosts the beneficial effects of rosuvastatin on mouse kidney. Amino Acids, 46(9), 2189\u20132203.", "ArticleIdList": ["PMC4133027", "24923264"]}, {"Citation": "D'Antona, G. , Tedesco, L. , Ruocco, C. , Corsetti, G. , Ragni, M. , Fossati, A. , Saba, E. , Fenaroli, F. , Montinaro, M. , & Carruba, M. O. (2016a). A peculiar formula of essential amino acids prevents rosuvastatin myopathy in mice. Antioxidants & Redox Signaling, 25(11), 595\u2013608.", "ArticleIdList": ["PMC5065032", "27245589"]}, {"Citation": "D'Antona, G. , Tedesco, L. , Ruocco, C. , Corsetti, G. , Ragni, M. , Fossati, A. , Saba, E. , Fenaroli, F. , Montinaro, M. , Carruba, M. O. , Valerio, A. , & Nisoli, E. (2016b). A peculiar formula of essential amino acids prevents rosuvastatin myopathy in mice. Antioxidants & Redox Signaling, 25(11), 595\u2013608.", "ArticleIdList": ["PMC5065032", "27245589"]}, {"Citation": "Davidson, M. H. (2002). Rosuvastatin: A highly efficacious statin for the treatment of dyslipidaemia. Expert Opinion on Investigational Drugs, 11(1), 125\u2013141.", "ArticleIdList": ["11772327"]}, {"Citation": "Desjardins, F. , Sekkali, B. , Verreth, W. , Pelat, M. , De Keyzer, D. , Mertens, A. , Smith, G. , Herregods, M. C. , Holvoet, P. , & Balligand, J. L. (2008). Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice. European Heart Journal, 29(1), 128\u2013137.", "ArticleIdList": ["18063594"]}, {"Citation": "Dhanani, Z. N. , Mann, G. , & Adegoke, O. A. J. (2019). Depletion of branched\u2010chain aminotransferase 2 (BCAT2) enzyme impairs myoblast survival and myotube formation. Physiological Reports, 7(23), e14299.", "ArticleIdList": ["PMC6908738", "31833233"]}, {"Citation": "Diaz\u2010Zagoya, J. C. , Marin\u2010Medina, A. , Zetina\u2010Esquivel, A. M. , Ble\u2010Castillo, J. L. , Castell\u2010Rodriguez, A. E. , Juarez\u2010Rojop, I. E. , & Miranda\u2010Zamora, R. (2021). Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice. Scientific Reports, 11(1), 15809.", "ArticleIdList": ["PMC8338935", "34349148"]}, {"Citation": "East, M. P. , Laitinen, T. , & Asquith, C. R. M. (2021). BCKDK: An emerging kinase target for metabolic diseases and cancer. Nature Reviews Drug Discovery, 20(7), 498.", "ArticleIdList": ["34117456"]}, {"Citation": "Farrar, C. , Houser, C. R. , & Clarke, S. (2005). Activation of the PI3K/Akt signal transduction pathway and increased levels of insulin receptor in protein repair\u2010deficient mice. Aging Cell, 4(1), 1\u201312.", "ArticleIdList": ["15659208"]}, {"Citation": "Gannag\u00e9\u2010Yared, M.\u2010H. , Azar, R. R. , Amm\u2010Azar, M. , Khalif\u00e9, S. , Germanos\u2010Haddad, M. , Neemtallah, R. , & Halaby, G. (2005). Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients. Metabolism, 54(7), 947\u2013951.", "ArticleIdList": ["15988706"]}, {"Citation": "Giesbertz, P. , & Daniel, H. (2016). Branched\u2010chain amino acids as biomarkers in diabetes. Current Opinion in Clinical Nutrition & Metabolic Care, 19(1), 48\u201354.", "ArticleIdList": ["26485337"]}, {"Citation": "Guclu, F. , Ozmen, B. , Hekimsoy, Z. , & Kirmaz, C. (2004). Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome. Biomedicine & Pharmacotherapy, 58(10), 614\u2013618.", "ArticleIdList": ["15589072"]}, {"Citation": "John, C. M. , Mohamed Yusof, N. I. S. , Abdul Aziz, S. H. , & Mohd Fauzi, F. (2018). Maternal cognitive impairment associated with gestational diabetes Mellitus\u2010A review of potential contributing mechanisms. International Journal of Molecular Sciences, 19(12), 3894.", "ArticleIdList": ["PMC6321050", "30563117"]}, {"Citation": "Klimentidis, Y. C. , Arora, A. , Newell, M. , Zhou, J. , Ordovas, J. M. , Renquist, B. J. , & Wood, A. C. (2020). Phenotypic and genetic characterization of lower LDL cholesterol and increased Type 2 diabetes risk in the UK Biobank. Diabetes, 69(10), 2194\u20132205.", "ArticleIdList": ["PMC7506834", "32493714"]}, {"Citation": "Koh, K. K. , Quon, M. J. , Han, S. H. , Lee, Y. , Kim, S. J. , & Shin, E. K. (2010). Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. Journal of the American College of Cardiology, 55(12), 1209\u20131216.", "ArticleIdList": ["PMC3016087", "20298928"]}, {"Citation": "Kostapanos, M. , Milionis, H. , Agouridis, A. D. , Rizos, C. , & Elisaf, M. (2009). Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose. International Journal of Clinical Practice, 63(9), 1308\u20131313.", "ArticleIdList": ["19691613"]}, {"Citation": "Lee, J. , & Kim, M. S. (2007). The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Research and Clinical Practice, 77(3), S49\u2013S57.", "ArticleIdList": ["17478001"]}, {"Citation": "Lian, K. , Guo, X. , Wang, Q. , Liu, Y. , Wang, R. T. , Gao, C. , Li, C. Y. , Li, C. X. , & Tao, L. (2020). PP2Cm overexpression alleviates MI/R injury mediated by a BCAA catabolism defect and oxidative stress in diabetic mice. European Journal of Pharmacology, 866, 172796.", "ArticleIdList": ["31738932"]}, {"Citation": "Lu, G. , Sun, H. , She, P. , Youn, J.\u2010Y. , Warburton, S. , Ping, P. , Vondriska, T. M. , Cai, H. , Lynch, C. J. , & Wang, Y. (2009). Protein phosphatase 2Cm is a critical regulator of branched\u2010chain amino acid catabolism in mice and cultured cells. The Journal of Clinical Investigation, 119(6), 1678\u20131687.", "ArticleIdList": ["PMC2689111", "19411760"]}, {"Citation": "Lu, J. , Xie, G. , Jia, W. , & Jia, W. (2013). Insulin resistance and the metabolism of branched\u2010chain amino acids. Frontiers of Medicine, 7(1), 53\u201359.", "ArticleIdList": ["23385611"]}, {"Citation": "Lynch, C. J. , & Adams, S. H. (2014). Branched\u2010chain amino acids in metabolic signalling and insulin resistance. Nature Reviews Endocrinology, 10(12), 723\u2013736.", "ArticleIdList": ["PMC4424797", "25287287"]}, {"Citation": "Mayanagi, K. , Katakam, P. V. , Gaspar, T. , Domoki, F. , & Busija, D. W. (2008). Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism, 28(12), 1927\u20131935.", "ArticleIdList": ["PMC2632795", "18665182"]}, {"Citation": "McManus, E. J. , Sakamoto, K. , Armit, L. J. , Ronaldson, L. , Shpiro, N. , Marquez, R. , & Alessi, D. R. (2005). Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. The EMBO Journal, 24(8), 1571\u20131583.", "ArticleIdList": ["PMC1142569", "15791206"]}, {"Citation": "Mirbolouk, M. , & Blaha, M. J. (2020). ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease. Cleveland Clinic Journal of Medicine, 87(4), 231.", "ArticleIdList": ["32238379"]}, {"Citation": "Mora, S. , Glynn, R. J. , Hsia, J. , MacFadyen, J. G. , Genest, J. , & Ridker, P. M. (2010). Statins for the primary prevention of cardiovascular events in women with elevated high\u2010sensitivity C\u2010reactive protein or dyslipidemia: Results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta\u2010analysis of women from primary prevention trials. Circulation, 121(9), 1069\u20131077.", "ArticleIdList": ["PMC4439924", "20176986"]}, {"Citation": "Neinast, M. , Murashige, D. , & Arany, Z. (2019). Branched chain amino acids. Annual Review of Physiology, 81(1), 139\u2013164.", "ArticleIdList": ["PMC6536377", "30485760"]}, {"Citation": "Newgard, C. B. (2012). Interplay between lipids and branched\u2010chain amino acids in development of insulin resistance. Cell Metabolism, 15(5), 606\u2013614.", "ArticleIdList": ["PMC3695706", "22560213"]}, {"Citation": "Ohmura, C. , Watada, H. , Hirose, T. , Tanaka, Y. , & Kawamori, R. (2005). Acute onset and worsening of diabetes concurrent with administration of statins. Endocrine Journal, 52(3), 369\u2013372.", "ArticleIdList": ["16006732"]}, {"Citation": "Okada, K. , Maeda, N. , Kikuchi, K. , Tatsukawa, M. , Sawayama, Y. , & Hayashi, J. (2005). Pravastatin improves insulin resistance in dyslipidemic patients. Journal of Atherosclerosis and Thrombosis, 12(6), 322\u2013329.", "ArticleIdList": ["16394616"]}, {"Citation": "Ostrowska, M. , Adamski, P. , Kozi\u0144ski, M. , Navarese, E. P. , & Kubica, J. (2015). Diabetogenic effect of statins: A comprehensive review on the clinical relevance, underlying pathomechanisms and rationale for tailored statin therapy. Medical Research Journal, 3(4), 145\u2013153."}, {"Citation": "Pantoja\u2010Torres, B. , Toro\u2010Huamanchumo, C. J. , Urrunaga\u2010Pastor, D. , Guarnizo\u2010Poma, M. , Lazaro\u2010Alcantara, H. , Paico\u2010Palacios, S. , del Carmen Ranilla\u2010Seguin, V. , Benites\u2010Zapata, V. A. , & Group, M. S. R. (2019). High triglycerides to HDL\u2010cholesterol ratio is associated with insulin resistance in normal\u2010weight healthy adults. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(1), 382\u2013388.", "ArticleIdList": ["30641729"]}, {"Citation": "Paoletti, R. , Fahmy, M. , Mahla, G. , Mizan, J. , & Southworth, H. (2001). Rosuvastatin demonstrates greater reduction of low\u2010density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: A randomized, double\u2010blind study. Journal of Cardiovascular Risk, 8(6), 383\u2013390.", "ArticleIdList": ["11873095"]}, {"Citation": "Preiss, D. , & Sattar, N. (2012). Pharmacotherapy: Statins and new\u2010onset diabetes\u2013the important questions. Nature Reviews Cardiology, 9(4), 190\u2013192.", "ArticleIdList": ["22330613"]}, {"Citation": "Ridker, P. M. , Danielson, E. , Fonseca, F. A. , Genest, J. , Gotto, A. M., Jr. , Kastelein, J. J. , Koenig, W. , Libby, P. , Lorenzatti, A. J. , MacFadyen, J. G. , Nordestgaard, B. G. , Shepherd, J. , Willerson, J. T. , Glynn, R. J. , & Group, J. S. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C\u2010reactive protein. New England Journal of Medicine, 359(21), 2195\u20132207.", "ArticleIdList": ["18997196"]}, {"Citation": "Ridker, P. M. , Danielson, E. , Fonseca, F. A. , Genest, J. , Gotto, A. M. Jr , Kastelein, J. J. , Koenig, W. , Libby, P. , Lorenzatti, A. J. , & MacFadyen, J. G. (2009). Reduction in C\u2010reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial. The Lancet, 373(9670), 1175\u20131182.", "ArticleIdList": ["19329177"]}, {"Citation": "Ruzzin, J. , Wagman, A. , & Jensen, J. (2005). Glucocorticoid\u2010induced insulin resistance in skeletal muscles: Defects in insulin signalling and the effects of a selective glycogen synthase kinase\u20103 inhibitor. Diabetologia, 48(10), 2119\u20132130.", "ArticleIdList": ["16078016"]}, {"Citation": "Salunkhe, V. A. , Mollet, I. G. , Ofori, J. K. , Malm, H. A. , Esguerra, J. L. , Reinbothe, T. M. , Stenkula, K. G. , Wendt, A. , Eliasson, L. , & Vikman, J. (2016). Dual effect of rosuvastatin on glucose homeostasis through improved insulin sensitivity and reduced insulin secretion. EBioMedicine, 10, 185\u2013194.", "ArticleIdList": ["PMC5006666", "27453321"]}, {"Citation": "Schiff, M. , de Baulny, H. O. , & Dionisi\u2010Vici, C. (2016). Branched\u2010chain organic acidurias/acidaemias. In Inborn metabolic diseases (pp. 277\u2013294). Springer."}, {"Citation": "Schultze, S. M. , Hemmings, B. A. , Niessen, M. , & Tschopp, O. (2012). PI3K/AKT, MAPK and AMPK signalling: Protein kinases in glucose homeostasis. Expert Reviews in Molecular Medicine, 14, e1.", "ArticleIdList": ["22233681"]}, {"Citation": "Tijeras\u2010Raballand, A. , Hainaud\u2010Hakim, P. , Contreres, J. O. , Gest, C. , Le Henaff, C. , Levy, B. I. , Pocard, M. , Soria, C. , & Dupuy, E. (2010). Rosuvastatin counteracts vessel arterialisation and sinusoid capillarisation, reduces tumour growth, and prolongs survival in murine hepatocellular carcinoma. Gastroenterology Research and Practice, 2010, 640797.", "ArticleIdList": ["PMC3082163", "21528105"]}, {"Citation": "Toth, P. P. , Farnier, M. , Tomassini, J. E. , Foody, J. M. , & Tershakovec, A. M. (2016). Statin combination therapy and cardiovascular risk reduction. Future Cardiology, 12(3), 289\u2013315.", "ArticleIdList": ["27079178"]}, {"Citation": "Velez, D. E. , Mestre\u2010Cordero, V. E. , Hermann, R. , Perego, J. , Harriet, S. , Fernandez\u2010Pazos, M. L. M. , Mourglia, J. , & Marina\u2010Prendes, M. G. (2020). Rosuvastatin protects isolated hearts against ischemia\u2010reperfusion injury: Role of Akt\u2010GSK\u20103beta, metabolic environment, and mitochondrial permeability transition pore. Journal of Physiology and Biochemistry, 76(1), 85\u201398.", "ArticleIdList": ["31916218"]}, {"Citation": "Wang, J. , Liu, Y. , Lian, K. , Shentu, X. , Fang, J. , Shao, J. , Chen, M. , Wang, Y. , Zhou, M. , & Sun, H. (2019). BCAA catabolic defect alters glucose metabolism in lean mice. Frontiers in Physiology, 10, 1140.", "ArticleIdList": ["PMC6738029", "31551816"]}, {"Citation": "Xue, P. , Zeng, F. , Duan, Q. , Xiao, J. , Liu, L. , Yuan, P. , Fan, L. , Sun, H. , Malyarenko, O. S. , Lu, H. , Xiu, R. , Liu, S. , Shao, C. , Zhang, J. , Yan, W. , Wang, Z. , Zheng, J. , & Zhu, F. (2017). BCKDK of BCAA Catabolism Cross\u2010talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer. EBioMedicine, 20, 50\u201360.", "ArticleIdList": ["PMC5478211", "28501528"]}, {"Citation": "Yada, T. , Nakata, M. , Shiraishi, T. , & Kakei, M. (1999). Inhibition by simvastatin, but not pravastatin, of glucose\u2010induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L\u2010type Ca2+ channels in rat islet \u03b2\u2010cells. British Journal of Pharmacology, 126(5), 1205\u20131213.", "ArticleIdList": ["PMC1565875", "10205010"]}, {"Citation": "Yoon, J. S. , & Lee, H. W. (2013). Diabetogenic effect of statins: A double\u2010edged sword? The Diabetes & Metabolism Journal, 37(6), 415\u2013422.", "ArticleIdList": ["PMC3881325", "24404512"]}, {"Citation": "Yoon, M. S. (2016). The emerging role of Branched\u2010Chain amino acids in insulin resistance and metabolism. Nutrients, 8(7), 405.", "ArticleIdList": ["PMC4963881", "27376324"]}, {"Citation": "Young, K. A. , Maturu, A. , Lorenzo, C. , Langefeld, C. D. , Wagenknecht, L. E. , Chen, Y.\u2010D. I. , Taylor, K. D. , Rotter, J. I. , Norris, J. M. , & Rasouli, N. (2019). The triglyceride to high\u2010density lipoprotein cholesterol (TG/HDL\u2010C) ratio as a predictor of insulin resistance, \u03b2\u2010cell function, and diabetes in Hispanics and African Americans. Journal of Diabetes and its Complications, 33(2), 118\u2013122.", "ArticleIdList": ["PMC6331279", "30522790"]}, {"Citation": "Zeybek, N. D. , Gulcelik, N. E. , Kaymaz, F. F. , Sarisozen, C. , Vural, I. , Bodur, E. , Canpinar, H. , Usman, A. , & Asan, E. (2011). Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells. Journal of Endocrinology, 210(1), 105\u2013115.", "ArticleIdList": ["21478229"]}, {"Citation": "Zhao, X. , Han, Q. , Liu, Y. , Sun, C. , Gang, X. , & Wang, G. (2016). The relationship between branched\u2010chain amino acid related metabolomic signature and insulin resistance: A systematic review. Journal of Diabetes Research, 2016, 1\u201312.", "ArticleIdList": ["PMC5014958", "27642608"]}, {"Citation": "Zhou, M. , Lu, G. , Gao, C. , Wang, Y. , & Sun, H. (2012). Tissue\u2010specific and nutrient regulation of the branched\u2010chain alpha\u2010keto acid dehydrogenase phosphatase, protein phosphatase 2Cm (PP2Cm). Journal of Biological Chemistry, 287(28), 23397\u201323406.", "ArticleIdList": ["PMC3390616", "22589535"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "5"}, {"Year": "2023", "Month": "4", "Day": "14"}, {"Year": "2023", "Month": "7", "Day": "3", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "5", "Day": "4", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "5", "Day": "4", "Hour": "4", "Minute": "13"}, {"Year": "2023", "Month": "5", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37139700", "PMC10988443", "10.1113/EP090305"]}}], "PubmedBookArticle": []}